ASGARD THERAPEUTICS Trademark

Trademark Overview


On Monday, November 14, 2022, a trademark application was filed for ASGARD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ASGARD THERAPEUTICS trademark a serial number of 79357230. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Asgard Therapeutics AB. The ASGARD THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in cancer immunotherapy; Pharmaceutical preparations for use in gene therapy; Pharmaceutical preparations for cell reprogramming
asgard therapeutics

General Information


Serial Number79357230
Word MarkASGARD THERAPEUTICS
Filing DateMonday, November 14, 2022
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7333962
Registration DateTuesday, March 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in cancer immunotherapy; Pharmaceutical preparations for use in gene therapy; Pharmaceutical preparations for cell reprogramming
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsgard Therapeutics AB
Party Type30 - Original Registrant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameAsgard Therapeutics AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameAsgard Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Trademark Events


Event DateEvent Description
Thursday, December 8, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 13, 2022APPLICATION FILING RECEIPT MAILED
Monday, August 28, 2023ASSIGNED TO EXAMINER
Monday, August 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, August 29, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 18, 2023REFUSAL PROCESSED BY MPU
Monday, September 18, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 10, 2023REFUSAL PROCESSED BY IB
Monday, November 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 20, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, January 8, 2024NOTIFICATION PROCESSED BY IB
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, June 27, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 16, 2024FINAL DISPOSITION PROCESSED
Thursday, October 17, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED